IRIS
MOROZZI, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.094
EU - Europa 5.254
AS - Asia 2.841
SA - Sud America 389
AF - Africa 105
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 16.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.992
CN - Cina 1.053
RU - Federazione Russa 980
GB - Regno Unito 933
SG - Singapore 920
IT - Italia 830
IE - Irlanda 654
UA - Ucraina 440
SE - Svezia 418
DE - Germania 338
BR - Brasile 337
FR - Francia 314
VN - Vietnam 219
HK - Hong Kong 207
FI - Finlandia 164
KR - Corea 140
IN - India 73
BD - Bangladesh 68
CA - Canada 58
ES - Italia 42
NL - Olanda 42
ZA - Sudafrica 34
CI - Costa d'Avorio 26
IQ - Iraq 26
BE - Belgio 25
TR - Turchia 24
MX - Messico 20
AR - Argentina 18
JP - Giappone 18
PL - Polonia 18
NG - Nigeria 14
CZ - Repubblica Ceca 13
PK - Pakistan 12
SA - Arabia Saudita 12
AT - Austria 11
ID - Indonesia 10
IR - Iran 9
MA - Marocco 8
VE - Venezuela 8
AU - Australia 7
CO - Colombia 6
EU - Europa 6
GR - Grecia 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
EG - Egitto 5
TN - Tunisia 5
UZ - Uzbekistan 5
CH - Svizzera 4
EC - Ecuador 4
IL - Israele 4
JM - Giamaica 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
RO - Romania 4
UY - Uruguay 4
BB - Barbados 3
BO - Bolivia 3
CL - Cile 3
DK - Danimarca 3
DZ - Algeria 3
KE - Kenya 3
OM - Oman 3
PH - Filippine 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BG - Bulgaria 2
CR - Costa Rica 2
JO - Giordania 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
QA - Qatar 2
RW - Ruanda 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BY - Bielorussia 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IM - Isola di Man 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
Totale 16.695
Salva come PNG Salva come JPEG
Città #
Menlo Park 1.653
Southend 804
Dallas 753
Dublin 641
Singapore 561
Ashburn 539
Fairfield 528
Chandler 400
Jacksonville 351
Santa Clara 342
San Jose 275
Moscow 272
Woodbridge 271
Beijing 260
Ann Arbor 231
Wilmington 220
Seattle 215
Hong Kong 200
Cambridge 181
Houston 179
Milan 173
The Dalles 138
Hefei 136
New York 133
Seoul 123
Princeton 120
Nanjing 118
Rome 103
Siena 96
Los Angeles 84
Ho Chi Minh City 78
Munich 64
Helsinki 60
San Diego 59
Lauterbourg 58
Boardman 53
Council Bluffs 52
Nanchang 48
San Mateo 41
Buffalo 40
Hanoi 40
Dearborn 35
São Paulo 32
Turku 31
Columbus 30
Johannesburg 29
Shenyang 29
Shanghai 28
Hebei 27
Toronto 27
Abidjan 26
Brussels 24
Figino 23
San Francisco 22
Tianjin 22
Frankfurt am Main 21
Kunming 21
Málaga 21
Orem 21
Chennai 19
London 19
Venezia 19
Falls Church 18
Changsha 16
Düsseldorf 16
Guangzhou 16
Jiaxing 16
Jinan 16
Boston 15
Chicago 15
Denver 15
Dong Ket 15
Montreal 15
Turin 15
Zhengzhou 15
Bengaluru 14
Brooklyn 14
Tokyo 14
Warsaw 14
Abuja 13
Lancaster 13
Mestre 12
Ningbo 12
Phoenix 12
Redondo Beach 12
Baghdad 11
Da Nang 11
Brno 10
Mumbai 10
Rio de Janeiro 10
Stockholm 10
Washington 10
Amsterdam 9
Atlanta 9
Belo Horizonte 9
Florence 9
Mexico City 9
Vienna 9
Biên Hòa 8
Charlotte 8
Totale 11.694
Salva come PNG Salva come JPEG
Nome #
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 486
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 424
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 421
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 364
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 314
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 313
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 313
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis 298
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 298
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 297
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 295
The Immunogenetics of the Antiphospholipid Syndrome, Anticardiolipin Antibodies, and Lupus Anticoagulant 281
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 276
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study 271
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 269
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 268
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 260
Anomalie cromosomiche, valutate come frequenza di micronuclei spontanei, in soggetti con fenomeno di Raynaud sospetto presclerodermico [Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon] 260
Antinuclear Human Autoantibodies as Markers in Nicotiana Tabacum Pollen Tubes 256
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 255
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 251
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 249
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 248
Chromosome aberrations in Raynaud's phenomenon 248
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies 244
Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis 243
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 242
Poly(ADP-ribose) polymerase activity in systemic lupus erythematosus and systemic sclerosis. 239
Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? 235
Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohoert of SLE patients 232
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 232
Comportamento delle purine plasmatiche e urinarie dopo dieta apurinica in soggetti normali e gottosi 232
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 231
Esame del liquido sinoviale 222
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 218
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study 215
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 213
Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis 212
Clearance of oxypurines and uric acid in gouty patients [Clearance delle ossipurine e dell'acido urico in soggetti gottosi] 207
Thiopurine methyltransferase activity in the erythrocytes of adults and children: and HPLC-linked assay 206
Ruolo degli autoanticorpi nella diagnosi della colangite sclerosante primitiva 206
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 205
Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis 205
Allelic variations of DPB1, DQA1, DQB1 and DRB1 and rheumatoid arthritis: further genetic and statistical considerations [Varianti alleliche dei DPB1, DQA1, DQB1, DRB1 e artite reumatoide: ulteriori considerazioni genetiche e statistiche] 201
Serologic profile and mortality rates of scleroderma renal crisis in Italy 200
Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) 198
Epidemiologic study about hyperuricemia's prevalence on an unselected champion of subjects, in a village of Siena's province 196
L'elettroforesi bidimensionale su gel di poliacrilamide nello studio dei profili proteici sierici nell'artrite reumatoide 195
Modification of DNA patterns in plasma and nucleated blood cells from systemic sclerosis patients 193
Semeiotica di laboratorio delle malattie reumatiche 189
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 189
Usefulness of the determination of C reactive protein and other acute phase proteins in rheumatoid arthritis [Utilità del dosaggio della proteina C reattiva e di altre proteine della fase acuta nell'artrite reumatoide] 188
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature 179
Evaluation of the clinical therapeutic response to oral gold salts in patients with rheumatoid arthritis 177
Lessons from the "Euro-Lupus Cohort" 176
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 174
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 171
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 169
HSP70-1 promoter region polymorphism tested in three autoimmune diseases 169
Immunogenetics of the antiphospholipid syndrome 164
Comparison of different methods for the detection ofanti-Ro/SSA antibodies in connective tissue diseases. 162
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 161
Human serum recognizes components of plant cells: New research perspectives [Sieri umani riconoscono componenti di cellule vegetali: Nuove prospettive di ricerca] 159
HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus : correlation with clinical and autoantibody subsets 157
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies 156
Is two dimensional polyacrilamide gel electrophoresis a usful technique for the study of serum protein profiles in rheumatoid arthritis 148
Effect of local corticosteroid injection in carpal tunnel syndrome: Clinical and electrophysiological aspects [Efficacia del trattamento con cortisonoci nella sindrome del tunnel carpale idiopatica: studio clinico e neurofisiologico] 144
Linee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Revision 2015 132
In vitro study on the possible inflammatory mechanism of ferrous ions: effect on the production of oxygen free radicals [Studi in vitro sul possibile meccanismo flogogeno degli ioni ferro: azione sulla produzione di radicali liberi dell'ossigeno] 129
Lesch-Nyhan syndrome: Observations on a clinical case [La sindrome di Lesch-Nyhan: osservazione di un caso clinico] 127
Immunogenetics of systemic lupus erythematosus: The contribution of DRB3 and DQB1 alleles [Immunogenetica del lupus eritematoso sistemico: il ruolo degli alleli DRB3 e DQB1] 118
null 117
PARP activity and NAD concentration in PMC from patients affected by systemic sclerosis and lupus erythematosus 117
The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics. 115
null 89
null 69
Il test ANA-reflex.The ANA-reflex test. 66
Antibodies to the lens and cornea in anti-DFS70-positive subjects 6
A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases. 4
Rheumatoid factor isotypes in patients with erosive osteoarthritis of the hand. 3
Multicentric evaluation of a second generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni. 2
Totale 16.763
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022897 59 108 51 108 39 20 41 38 31 102 73 227
2022/20231.406 86 122 203 205 146 270 16 117 145 25 56 15
2023/20241.062 41 22 86 93 41 299 336 24 12 9 11 88
2024/20252.029 35 112 174 102 301 109 44 122 190 79 243 518
2025/20264.983 390 689 556 543 1.030 249 509 89 138 234 103 453
2026/2027135 135 0 0 0 0 0 0 0 0 0 0 0
Totale 16.763